Adeno-associated virus and development of cervical neoplasia

Howard Strickler, Raphael Viscidi, Carlos Escoffery, Carole Rattray, Karen L. Kotloff, Janet Goldberg, Angela Manns, Charles Rabkin, Richard Daniel, Barrie Hanchard, Claudette Brown, Martha Hutchinson, David Zanizer, Joel Palefsky, Robert D. Burk, Beverly Cranston, Barbara Clayman, Keerti V. Shah

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Evidence from several sources has suggested that adeno-associated virus (AAV) infection might protect against cervical cancer, in part, by interfering with human papillomavirus (HPV)-induced tumorigenesis. Detection of AAV type 2 (AAV-2) DNA in cervical tissues has been reported. However, there have been few in vivo studies of women with cervical HPV infection or neoplasia, and these have reported inconsistent results. Therefore, we used polymerase chain reaction (PCR) assays targeted to the AAV-2 rep and cap genes to test tissue specimens from women in an epidemiological study of cervical neoplasia in Jamaica. We tested 105 women with low-grade cervical intraepithelial neoplasia (CIN-1), 92 women with CIN-3/carcinoma in situ or invasive cancer (CIN-3/CA), and 94 normal subjects. PCR amplification of human β-globin DNA was found in almost all cervical specimens, indicating that these materials were adequate for PCR testing. The prevalence of HPV DNA, determined by HPV L1 consensus primer PCR was, as expected, strongly associated with presence and grade of neoplasia. Each of the AAV PCR assays detected as few as 10 copies of the virus genome. However, none of the 291 cervical specimens from Jamaican subjects tested positive for AAV DNA. Negative AAV PCR results were also obtained in tests of cervical samples from 79 university students in the United States. Exposure to AAV was assessed further by serology. Using a whole virus AAV-2 sandwich enzyme-linked immunosorbent assay, we found no relationship between AAV antibodies and presence or grade of neoplasia in either the Jamaican study subjects or women enrolled in a U.S. cervical cancer case (n = 74) -control (n = 77) study. Overall, the data provide no evidence that AAV infection plays a role in cervical tumorigenesis or that AAV commonly infects cervical epithelial cells.

Original languageEnglish (US)
Pages (from-to)60-65
Number of pages6
JournalJournal of Medical Virology
Volume59
Issue number1
DOIs
StatePublished - 1999

Fingerprint

Dependovirus
Neoplasms
Polymerase Chain Reaction
DNA
Virus Diseases
Uterine Cervical Neoplasms
Carcinogenesis
Viruses
Jamaica
Cervical Intraepithelial Neoplasia
Papillomavirus Infections
Globins
Carcinoma in Situ
Serology
Epidemiologic Studies
Epithelial Cells
Enzyme-Linked Immunosorbent Assay
Genome
Students

Keywords

  • AAV
  • Adeno-associated virus
  • Cervical cancer
  • CIN
  • HPV
  • Human papillomavirus

ASJC Scopus subject areas

  • Virology

Cite this

Adeno-associated virus and development of cervical neoplasia. / Strickler, Howard; Viscidi, Raphael; Escoffery, Carlos; Rattray, Carole; Kotloff, Karen L.; Goldberg, Janet; Manns, Angela; Rabkin, Charles; Daniel, Richard; Hanchard, Barrie; Brown, Claudette; Hutchinson, Martha; Zanizer, David; Palefsky, Joel; Burk, Robert D.; Cranston, Beverly; Clayman, Barbara; Shah, Keerti V.

In: Journal of Medical Virology, Vol. 59, No. 1, 1999, p. 60-65.

Research output: Contribution to journalArticle

Strickler, H, Viscidi, R, Escoffery, C, Rattray, C, Kotloff, KL, Goldberg, J, Manns, A, Rabkin, C, Daniel, R, Hanchard, B, Brown, C, Hutchinson, M, Zanizer, D, Palefsky, J, Burk, RD, Cranston, B, Clayman, B & Shah, KV 1999, 'Adeno-associated virus and development of cervical neoplasia', Journal of Medical Virology, vol. 59, no. 1, pp. 60-65. https://doi.org/10.1002/(SICI)1096-9071(199909)59:1<60::AID-JMV10>3.0.CO;2-8
Strickler, Howard ; Viscidi, Raphael ; Escoffery, Carlos ; Rattray, Carole ; Kotloff, Karen L. ; Goldberg, Janet ; Manns, Angela ; Rabkin, Charles ; Daniel, Richard ; Hanchard, Barrie ; Brown, Claudette ; Hutchinson, Martha ; Zanizer, David ; Palefsky, Joel ; Burk, Robert D. ; Cranston, Beverly ; Clayman, Barbara ; Shah, Keerti V. / Adeno-associated virus and development of cervical neoplasia. In: Journal of Medical Virology. 1999 ; Vol. 59, No. 1. pp. 60-65.
@article{40a04ba728bb47978bb83262bd21fdd9,
title = "Adeno-associated virus and development of cervical neoplasia",
abstract = "Evidence from several sources has suggested that adeno-associated virus (AAV) infection might protect against cervical cancer, in part, by interfering with human papillomavirus (HPV)-induced tumorigenesis. Detection of AAV type 2 (AAV-2) DNA in cervical tissues has been reported. However, there have been few in vivo studies of women with cervical HPV infection or neoplasia, and these have reported inconsistent results. Therefore, we used polymerase chain reaction (PCR) assays targeted to the AAV-2 rep and cap genes to test tissue specimens from women in an epidemiological study of cervical neoplasia in Jamaica. We tested 105 women with low-grade cervical intraepithelial neoplasia (CIN-1), 92 women with CIN-3/carcinoma in situ or invasive cancer (CIN-3/CA), and 94 normal subjects. PCR amplification of human β-globin DNA was found in almost all cervical specimens, indicating that these materials were adequate for PCR testing. The prevalence of HPV DNA, determined by HPV L1 consensus primer PCR was, as expected, strongly associated with presence and grade of neoplasia. Each of the AAV PCR assays detected as few as 10 copies of the virus genome. However, none of the 291 cervical specimens from Jamaican subjects tested positive for AAV DNA. Negative AAV PCR results were also obtained in tests of cervical samples from 79 university students in the United States. Exposure to AAV was assessed further by serology. Using a whole virus AAV-2 sandwich enzyme-linked immunosorbent assay, we found no relationship between AAV antibodies and presence or grade of neoplasia in either the Jamaican study subjects or women enrolled in a U.S. cervical cancer case (n = 74) -control (n = 77) study. Overall, the data provide no evidence that AAV infection plays a role in cervical tumorigenesis or that AAV commonly infects cervical epithelial cells.",
keywords = "AAV, Adeno-associated virus, Cervical cancer, CIN, HPV, Human papillomavirus",
author = "Howard Strickler and Raphael Viscidi and Carlos Escoffery and Carole Rattray and Kotloff, {Karen L.} and Janet Goldberg and Angela Manns and Charles Rabkin and Richard Daniel and Barrie Hanchard and Claudette Brown and Martha Hutchinson and David Zanizer and Joel Palefsky and Burk, {Robert D.} and Beverly Cranston and Barbara Clayman and Shah, {Keerti V.}",
year = "1999",
doi = "10.1002/(SICI)1096-9071(199909)59:1<60::AID-JMV10>3.0.CO;2-8",
language = "English (US)",
volume = "59",
pages = "60--65",
journal = "Journal of Medical Virology",
issn = "0146-6615",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Adeno-associated virus and development of cervical neoplasia

AU - Strickler, Howard

AU - Viscidi, Raphael

AU - Escoffery, Carlos

AU - Rattray, Carole

AU - Kotloff, Karen L.

AU - Goldberg, Janet

AU - Manns, Angela

AU - Rabkin, Charles

AU - Daniel, Richard

AU - Hanchard, Barrie

AU - Brown, Claudette

AU - Hutchinson, Martha

AU - Zanizer, David

AU - Palefsky, Joel

AU - Burk, Robert D.

AU - Cranston, Beverly

AU - Clayman, Barbara

AU - Shah, Keerti V.

PY - 1999

Y1 - 1999

N2 - Evidence from several sources has suggested that adeno-associated virus (AAV) infection might protect against cervical cancer, in part, by interfering with human papillomavirus (HPV)-induced tumorigenesis. Detection of AAV type 2 (AAV-2) DNA in cervical tissues has been reported. However, there have been few in vivo studies of women with cervical HPV infection or neoplasia, and these have reported inconsistent results. Therefore, we used polymerase chain reaction (PCR) assays targeted to the AAV-2 rep and cap genes to test tissue specimens from women in an epidemiological study of cervical neoplasia in Jamaica. We tested 105 women with low-grade cervical intraepithelial neoplasia (CIN-1), 92 women with CIN-3/carcinoma in situ or invasive cancer (CIN-3/CA), and 94 normal subjects. PCR amplification of human β-globin DNA was found in almost all cervical specimens, indicating that these materials were adequate for PCR testing. The prevalence of HPV DNA, determined by HPV L1 consensus primer PCR was, as expected, strongly associated with presence and grade of neoplasia. Each of the AAV PCR assays detected as few as 10 copies of the virus genome. However, none of the 291 cervical specimens from Jamaican subjects tested positive for AAV DNA. Negative AAV PCR results were also obtained in tests of cervical samples from 79 university students in the United States. Exposure to AAV was assessed further by serology. Using a whole virus AAV-2 sandwich enzyme-linked immunosorbent assay, we found no relationship between AAV antibodies and presence or grade of neoplasia in either the Jamaican study subjects or women enrolled in a U.S. cervical cancer case (n = 74) -control (n = 77) study. Overall, the data provide no evidence that AAV infection plays a role in cervical tumorigenesis or that AAV commonly infects cervical epithelial cells.

AB - Evidence from several sources has suggested that adeno-associated virus (AAV) infection might protect against cervical cancer, in part, by interfering with human papillomavirus (HPV)-induced tumorigenesis. Detection of AAV type 2 (AAV-2) DNA in cervical tissues has been reported. However, there have been few in vivo studies of women with cervical HPV infection or neoplasia, and these have reported inconsistent results. Therefore, we used polymerase chain reaction (PCR) assays targeted to the AAV-2 rep and cap genes to test tissue specimens from women in an epidemiological study of cervical neoplasia in Jamaica. We tested 105 women with low-grade cervical intraepithelial neoplasia (CIN-1), 92 women with CIN-3/carcinoma in situ or invasive cancer (CIN-3/CA), and 94 normal subjects. PCR amplification of human β-globin DNA was found in almost all cervical specimens, indicating that these materials were adequate for PCR testing. The prevalence of HPV DNA, determined by HPV L1 consensus primer PCR was, as expected, strongly associated with presence and grade of neoplasia. Each of the AAV PCR assays detected as few as 10 copies of the virus genome. However, none of the 291 cervical specimens from Jamaican subjects tested positive for AAV DNA. Negative AAV PCR results were also obtained in tests of cervical samples from 79 university students in the United States. Exposure to AAV was assessed further by serology. Using a whole virus AAV-2 sandwich enzyme-linked immunosorbent assay, we found no relationship between AAV antibodies and presence or grade of neoplasia in either the Jamaican study subjects or women enrolled in a U.S. cervical cancer case (n = 74) -control (n = 77) study. Overall, the data provide no evidence that AAV infection plays a role in cervical tumorigenesis or that AAV commonly infects cervical epithelial cells.

KW - AAV

KW - Adeno-associated virus

KW - Cervical cancer

KW - CIN

KW - HPV

KW - Human papillomavirus

UR - http://www.scopus.com/inward/record.url?scp=0032780492&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032780492&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1096-9071(199909)59:1<60::AID-JMV10>3.0.CO;2-8

DO - 10.1002/(SICI)1096-9071(199909)59:1<60::AID-JMV10>3.0.CO;2-8

M3 - Article

VL - 59

SP - 60

EP - 65

JO - Journal of Medical Virology

JF - Journal of Medical Virology

SN - 0146-6615

IS - 1

ER -